カテゴリー： Market Monitor Global, 世界, 医療/バイオ

腫瘍学（抗がん剤）の世界市場見通し2023年-2029年

◆英語タイトル：Oncology (Anti-cancer Drugs) Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5826）◆商品コード：MMG23JU5826
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：78
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥487,500見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥633,750見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥731,250見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Oncology (Anti-cancer Drugs) Market 調査レポートは次の情報を含め、グローバルにおけるの腫瘍学（抗がん剤）市場規模と予測を収録しています。・世界の腫瘍学（抗がん剤）市場：売上、2018年-2023年、2024年-2029年
・世界の腫瘍学（抗がん剤）市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の腫瘍学（抗がん剤）市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「血液がん」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

腫瘍学（抗がん剤）のグローバル主要企業は、Roche、 Novartis、 Celgene、 Amgen、 Johnson & Johnson、 GlaxoSmithKline、 Eli lilly & Co、 Pfizer、 Merck & Co.、 Sanofiなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、腫瘍学（抗がん剤）のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の腫瘍学（抗がん剤）市場：タイプ別、2018年-2023年、2024年-2029年
世界の腫瘍学（抗がん剤）市場：タイプ別市場シェア、2022年
・血液がん、乳がん、消化器がん、前立腺がん、その他

世界の腫瘍学（抗がん剤）市場：用途別、2018年-2023年、2024年-2029年
世界の腫瘍学（抗がん剤）市場：用途別市場シェア、2022年
・化学療法、標的療法、免疫療法（生物学的療法）、ホルモン療法、その他

世界の腫瘍学（抗がん剤）市場：地域・国別、2018年-2023年、2024年-2029年
世界の腫瘍学（抗がん剤）市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における腫瘍学（抗がん剤）のグローバル売上、2018年-2023年
・主要企業における腫瘍学（抗がん剤）のグローバル売上シェア、2022年
・主要企業における腫瘍学（抗がん剤）のグローバル販売量、2018年-2023年
・主要企業における腫瘍学（抗がん剤）のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Roche、 Novartis、 Celgene、 Amgen、 Johnson & Johnson、 GlaxoSmithKline、 Eli lilly & Co、 Pfizer、 Merck & Co.、 Sanofi

*************************************************************

・調査・分析レポートの概要
腫瘍学（抗がん剤）市場の定義
市場セグメント
世界の腫瘍学（抗がん剤）市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の腫瘍学（抗がん剤）市場規模
世界の腫瘍学（抗がん剤）市場規模：2022年 VS 2029年
世界の腫瘍学（抗がん剤）市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの腫瘍学（抗がん剤）の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の腫瘍学（抗がん剤）製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：血液がん、乳がん、消化器がん、前立腺がん、その他
腫瘍学（抗がん剤）のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：化学療法、標的療法、免疫療法（生物学的療法）、ホルモン療法、その他
腫瘍学（抗がん剤）の用途別グローバル売上・予測

・地域別市場分析
地域別腫瘍学（抗がん剤）市場規模 2022年と2029年
地域別腫瘍学（抗がん剤）売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Roche、 Novartis、 Celgene、 Amgen、 Johnson & Johnson、 GlaxoSmithKline、 Eli lilly & Co、 Pfizer、 Merck & Co.、 Sanofi
...

This report aims to provide a comprehensive presentation of the global market for Oncology (Anti-cancer Drugs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology (Anti-cancer Drugs). This report contains market size and forecasts of Oncology (Anti-cancer Drugs) in global, including the following market information:
Global Oncology (Anti-cancer Drugs) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Oncology (Anti-cancer Drugs) Market Sales, 2018-2023, 2024-2029, (K MT)
Global top five Oncology (Anti-cancer Drugs) companies in 2022 (%)
The global Oncology (Anti-cancer Drugs) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Blood Cancer Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Oncology (Anti-cancer Drugs) include Roche, Novartis, Celgene, Amgen, Johnson & Johnson, GlaxoSmithKline, Eli lilly & Co, Pfizer and Merck & Co., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oncology (Anti-cancer Drugs) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oncology (Anti-cancer Drugs) Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Oncology (Anti-cancer Drugs) Market Segment Percentages, by Type, 2022 (%)
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Others
Global Oncology (Anti-cancer Drugs) Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Oncology (Anti-cancer Drugs) Market Segment Percentages, by Application, 2022 (%)
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others
Global Oncology (Anti-cancer Drugs) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Oncology (Anti-cancer Drugs) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oncology (Anti-cancer Drugs) revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Oncology (Anti-cancer Drugs) revenues share in global market, 2022 (%)
Key companies Oncology (Anti-cancer Drugs) sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Oncology (Anti-cancer Drugs) sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Novartis
Celgene
Amgen
Johnson & Johnson
GlaxoSmithKline
Eli lilly & Co
Pfizer
Merck & Co.
Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oncology (Anti-cancer Drugs), market overview.
Chapter 2: Global Oncology (Anti-cancer Drugs) market size in revenue and volume.
Chapter 3: Detailed analysis of Oncology (Anti-cancer Drugs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oncology (Anti-cancer Drugs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Oncology (Anti-cancer Drugs) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Oncology (Anti-cancer Drugs) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncology (Anti-cancer Drugs) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncology (Anti-cancer Drugs) Overall Market Size
2.1 Global Oncology (Anti-cancer Drugs) Market Size: 2022 VS 2029
2.2 Global Oncology (Anti-cancer Drugs) Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Oncology (Anti-cancer Drugs) Sales: 2018-2029
3 Company Landscape
3.1 Top Oncology (Anti-cancer Drugs) Players in Global Market
3.2 Top Global Oncology (Anti-cancer Drugs) Companies Ranked by Revenue
3.3 Global Oncology (Anti-cancer Drugs) Revenue by Companies
3.4 Global Oncology (Anti-cancer Drugs) Sales by Companies
3.5 Global Oncology (Anti-cancer Drugs) Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Oncology (Anti-cancer Drugs) Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Oncology (Anti-cancer Drugs) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oncology (Anti-cancer Drugs) Players in Global Market
3.8.1 List of Global Tier 1 Oncology (Anti-cancer Drugs) Companies
3.8.2 List of Global Tier 2 and Tier 3 Oncology (Anti-cancer Drugs) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Oncology (Anti-cancer Drugs) Market Size Markets, 2022 & 2029
4.1.2 Blood Cancer
4.1.3 Breast Cancer
4.1.4 Gastrointestinal Cancer
4.1.5 Prostate Cancer
4.1.6 Others
4.2 By Type – Global Oncology (Anti-cancer Drugs) Revenue & Forecasts
4.2.1 By Type – Global Oncology (Anti-cancer Drugs) Revenue, 2018-2023
4.2.2 By Type – Global Oncology (Anti-cancer Drugs) Revenue, 2024-2029
4.2.3 By Type – Global Oncology (Anti-cancer Drugs) Revenue Market Share, 2018-2029
4.3 By Type – Global Oncology (Anti-cancer Drugs) Sales & Forecasts
4.3.1 By Type – Global Oncology (Anti-cancer Drugs) Sales, 2018-2023
4.3.2 By Type – Global Oncology (Anti-cancer Drugs) Sales, 2024-2029
4.3.3 By Type – Global Oncology (Anti-cancer Drugs) Sales Market Share, 2018-2029
4.4 By Type – Global Oncology (Anti-cancer Drugs) Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Oncology (Anti-cancer Drugs) Market Size, 2022 & 2029
5.1.2 Chemotherapy
5.1.3 Targeted Therapy
5.1.4 Immunotherapy (Biologic Therapy)
5.1.5 Hormonal Therapy
5.1.6 Others
5.2 By Application – Global Oncology (Anti-cancer Drugs) Revenue & Forecasts
5.2.1 By Application – Global Oncology (Anti-cancer Drugs) Revenue, 2018-2023
5.2.2 By Application – Global Oncology (Anti-cancer Drugs) Revenue, 2024-2029
5.2.3 By Application – Global Oncology (Anti-cancer Drugs) Revenue Market Share, 2018-2029
5.3 By Application – Global Oncology (Anti-cancer Drugs) Sales & Forecasts
5.3.1 By Application – Global Oncology (Anti-cancer Drugs) Sales, 2018-2023
5.3.2 By Application – Global Oncology (Anti-cancer Drugs) Sales, 2024-2029
5.3.3 By Application – Global Oncology (Anti-cancer Drugs) Sales Market Share, 2018-2029
5.4 By Application – Global Oncology (Anti-cancer Drugs) Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Oncology (Anti-cancer Drugs) Market Size, 2022 & 2029
6.2 By Region – Global Oncology (Anti-cancer Drugs) Revenue & Forecasts
6.2.1 By Region – Global Oncology (Anti-cancer Drugs) Revenue, 2018-2023
6.2.2 By Region – Global Oncology (Anti-cancer Drugs) Revenue, 2024-2029
6.2.3 By Region – Global Oncology (Anti-cancer Drugs) Revenue Market Share, 2018-2029
6.3 By Region – Global Oncology (Anti-cancer Drugs) Sales & Forecasts
6.3.1 By Region – Global Oncology (Anti-cancer Drugs) Sales, 2018-2023
6.3.2 By Region – Global Oncology (Anti-cancer Drugs) Sales, 2024-2029
6.3.3 By Region – Global Oncology (Anti-cancer Drugs) Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Oncology (Anti-cancer Drugs) Revenue, 2018-2029
6.4.2 By Country – North America Oncology (Anti-cancer Drugs) Sales, 2018-2029
6.4.3 US Oncology (Anti-cancer Drugs) Market Size, 2018-2029
6.4.4 Canada Oncology (Anti-cancer Drugs) Market Size, 2018-2029
6.4.5 Mexico Oncology (Anti-cancer Drugs) Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Oncology (Anti-cancer Drugs) Revenue, 2018-2029
6.5.2 By Country – Europe Oncology (Anti-cancer Drugs) Sales, 2018-2029
6.5.3 Germany Oncology (Anti-cancer Drugs) Market Size, 2018-2029
6.5.4 France Oncology (Anti-cancer Drugs) Market Size, 2018-2029
6.5.5 U.K. Oncology (Anti-cancer Drugs) Market Size, 2018-2029
6.5.6 Italy Oncology (Anti-cancer Drugs) Market Size, 2018-2029
6.5.7 Russia Oncology (Anti-cancer Drugs) Market Size, 2018-2029
6.5.8 Nordic Countries Oncology (Anti-cancer Drugs) Market Size, 2018-2029
6.5.9 Benelux Oncology (Anti-cancer Drugs) Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Oncology (Anti-cancer Drugs) Revenue, 2018-2029
6.6.2 By Region – Asia Oncology (Anti-cancer Drugs) Sales, 2018-2029
6.6.3 China Oncology (Anti-cancer Drugs) Market Size, 2018-2029
6.6.4 Japan Oncology (Anti-cancer Drugs) Market Size, 2018-2029
6.6.5 South Korea Oncology (Anti-cancer Drugs) Market Size, 2018-2029
6.6.6 Southeast Asia Oncology (Anti-cancer Drugs) Market Size, 2018-2029
6.6.7 India Oncology (Anti-cancer Drugs) Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Oncology (Anti-cancer Drugs) Revenue, 2018-2029
6.7.2 By Country – South America Oncology (Anti-cancer Drugs) Sales, 2018-2029
6.7.3 Brazil Oncology (Anti-cancer Drugs) Market Size, 2018-2029
6.7.4 Argentina Oncology (Anti-cancer Drugs) Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Oncology (Anti-cancer Drugs) Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Oncology (Anti-cancer Drugs) Sales, 2018-2029
6.8.3 Turkey Oncology (Anti-cancer Drugs) Market Size, 2018-2029
6.8.4 Israel Oncology (Anti-cancer Drugs) Market Size, 2018-2029
6.8.5 Saudi Arabia Oncology (Anti-cancer Drugs) Market Size, 2018-2029
6.8.6 UAE Oncology (Anti-cancer Drugs) Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Oncology (Anti-cancer Drugs) Major Product Offerings
7.1.4 Roche Oncology (Anti-cancer Drugs) Sales and Revenue in Global (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Oncology (Anti-cancer Drugs) Major Product Offerings
7.2.4 Novartis Oncology (Anti-cancer Drugs) Sales and Revenue in Global (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Celgene
7.3.1 Celgene Company Summary
7.3.2 Celgene Business Overview
7.3.3 Celgene Oncology (Anti-cancer Drugs) Major Product Offerings
7.3.4 Celgene Oncology (Anti-cancer Drugs) Sales and Revenue in Global (2018-2023)
7.3.5 Celgene Key News & Latest Developments
7.4 Amgen
7.4.1 Amgen Company Summary
7.4.2 Amgen Business Overview
7.4.3 Amgen Oncology (Anti-cancer Drugs) Major Product Offerings
7.4.4 Amgen Oncology (Anti-cancer Drugs) Sales and Revenue in Global (2018-2023)
7.4.5 Amgen Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Oncology (Anti-cancer Drugs) Major Product Offerings
7.5.4 Johnson & Johnson Oncology (Anti-cancer Drugs) Sales and Revenue in Global (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Oncology (Anti-cancer Drugs) Major Product Offerings
7.6.4 GlaxoSmithKline Oncology (Anti-cancer Drugs) Sales and Revenue in Global (2018-2023)
7.6.5 GlaxoSmithKline Key News & Latest Developments
7.7 Eli lilly & Co
7.7.1 Eli lilly & Co Company Summary
7.7.2 Eli lilly & Co Business Overview
7.7.3 Eli lilly & Co Oncology (Anti-cancer Drugs) Major Product Offerings
7.7.4 Eli lilly & Co Oncology (Anti-cancer Drugs) Sales and Revenue in Global (2018-2023)
7.7.5 Eli lilly & Co Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Oncology (Anti-cancer Drugs) Major Product Offerings
7.8.4 Pfizer Oncology (Anti-cancer Drugs) Sales and Revenue in Global (2018-2023)
7.8.5 Pfizer Key News & Latest Developments
7.9 Merck & Co.
7.9.1 Merck & Co. Company Summary
7.9.2 Merck & Co. Business Overview
7.9.3 Merck & Co. Oncology (Anti-cancer Drugs) Major Product Offerings
7.9.4 Merck & Co. Oncology (Anti-cancer Drugs) Sales and Revenue in Global (2018-2023)
7.9.5 Merck & Co. Key News & Latest Developments
7.10 Sanofi
7.10.1 Sanofi Company Summary
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Oncology (Anti-cancer Drugs) Major Product Offerings
7.10.4 Sanofi Oncology (Anti-cancer Drugs) Sales and Revenue in Global (2018-2023)
7.10.5 Sanofi Key News & Latest Developments
8 Global Oncology (Anti-cancer Drugs) Production Capacity, Analysis
8.1 Global Oncology (Anti-cancer Drugs) Production Capacity, 2018-2029
8.2 Oncology (Anti-cancer Drugs) Production Capacity of Key Manufacturers in Global Market
8.3 Global Oncology (Anti-cancer Drugs) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Oncology (Anti-cancer Drugs) Supply Chain Analysis
10.1 Oncology (Anti-cancer Drugs) Industry Value Chain
10.2 Oncology (Anti-cancer Drugs) Upstream Market
10.3 Oncology (Anti-cancer Drugs) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Oncology (Anti-cancer Drugs) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Oncology (Anti-cancer Drugs) in Global Market
Table 2. Top Oncology (Anti-cancer Drugs) Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Oncology (Anti-cancer Drugs) Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Oncology (Anti-cancer Drugs) Revenue Share by Companies, 2018-2023
Table 5. Global Oncology (Anti-cancer Drugs) Sales by Companies, (K MT), 2018-2023
Table 6. Global Oncology (Anti-cancer Drugs) Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Oncology (Anti-cancer Drugs) Price (2018-2023) & (USD/MT)
Table 8. Global Manufacturers Oncology (Anti-cancer Drugs) Product Type
Table 9. List of Global Tier 1 Oncology (Anti-cancer Drugs) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncology (Anti-cancer Drugs) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Oncology (Anti-cancer Drugs) Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Oncology (Anti-cancer Drugs) Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Oncology (Anti-cancer Drugs) Sales (K MT), 2018-2023
Table 15. By Type - Global Oncology (Anti-cancer Drugs) Sales (K MT), 2024-2029
Table 16. By Application – Global Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Oncology (Anti-cancer Drugs) Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Oncology (Anti-cancer Drugs) Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Oncology (Anti-cancer Drugs) Sales (K MT), 2018-2023
Table 20. By Application - Global Oncology (Anti-cancer Drugs) Sales (K MT), 2024-2029
Table 21. By Region – Global Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Oncology (Anti-cancer Drugs) Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Oncology (Anti-cancer Drugs) Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Oncology (Anti-cancer Drugs) Sales (K MT), 2018-2023
Table 25. By Region - Global Oncology (Anti-cancer Drugs) Sales (K MT), 2024-2029
Table 26. By Country - North America Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Oncology (Anti-cancer Drugs) Sales, (K MT), 2018-2023
Table 29. By Country - North America Oncology (Anti-cancer Drugs) Sales, (K MT), 2024-2029
Table 30. By Country - Europe Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Oncology (Anti-cancer Drugs) Sales, (K MT), 2018-2023
Table 33. By Country - Europe Oncology (Anti-cancer Drugs) Sales, (K MT), 2024-2029
Table 34. By Region - Asia Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Oncology (Anti-cancer Drugs) Sales, (K MT), 2018-2023
Table 37. By Region - Asia Oncology (Anti-cancer Drugs) Sales, (K MT), 2024-2029
Table 38. By Country - South America Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Oncology (Anti-cancer Drugs) Sales, (K MT), 2018-2023
Table 41. By Country - South America Oncology (Anti-cancer Drugs) Sales, (K MT), 2024-2029
Table 42. By Country - Middle East & Africa Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Oncology (Anti-cancer Drugs) Sales, (K MT), 2018-2023
Table 45. By Country - Middle East & Africa Oncology (Anti-cancer Drugs) Sales, (K MT), 2024-2029
Table 46. Roche Company Summary
Table 47. Roche Oncology (Anti-cancer Drugs) Product Offerings
Table 48. Roche Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 49. Roche Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Oncology (Anti-cancer Drugs) Product Offerings
Table 52. Novartis Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. Celgene Company Summary
Table 55. Celgene Oncology (Anti-cancer Drugs) Product Offerings
Table 56. Celgene Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 57. Celgene Key News & Latest Developments
Table 58. Amgen Company Summary
Table 59. Amgen Oncology (Anti-cancer Drugs) Product Offerings
Table 60. Amgen Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 61. Amgen Key News & Latest Developments
Table 62. Johnson & Johnson Company Summary
Table 63. Johnson & Johnson Oncology (Anti-cancer Drugs) Product Offerings
Table 64. Johnson & Johnson Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 65. Johnson & Johnson Key News & Latest Developments
Table 66. GlaxoSmithKline Company Summary
Table 67. GlaxoSmithKline Oncology (Anti-cancer Drugs) Product Offerings
Table 68. GlaxoSmithKline Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 69. GlaxoSmithKline Key News & Latest Developments
Table 70. Eli lilly & Co Company Summary
Table 71. Eli lilly & Co Oncology (Anti-cancer Drugs) Product Offerings
Table 72. Eli lilly & Co Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 73. Eli lilly & Co Key News & Latest Developments
Table 74. Pfizer Company Summary
Table 75. Pfizer Oncology (Anti-cancer Drugs) Product Offerings
Table 76. Pfizer Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 77. Pfizer Key News & Latest Developments
Table 78. Merck & Co. Company Summary
Table 79. Merck & Co. Oncology (Anti-cancer Drugs) Product Offerings
Table 80. Merck & Co. Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 81. Merck & Co. Key News & Latest Developments
Table 82. Sanofi Company Summary
Table 83. Sanofi Oncology (Anti-cancer Drugs) Product Offerings
Table 84. Sanofi Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 85. Sanofi Key News & Latest Developments
Table 86. Oncology (Anti-cancer Drugs) Production Capacity (K MT) of Key Manufacturers in Global Market, 2021-2023 (K MT)
Table 87. Global Oncology (Anti-cancer Drugs) Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Oncology (Anti-cancer Drugs) Production by Region, 2018-2023 (K MT)
Table 89. Global Oncology (Anti-cancer Drugs) Production by Region, 2024-2029 (K MT)
Table 90. Oncology (Anti-cancer Drugs) Market Opportunities & Trends in Global Market
Table 91. Oncology (Anti-cancer Drugs) Market Drivers in Global Market
Table 92. Oncology (Anti-cancer Drugs) Market Restraints in Global Market
Table 93. Oncology (Anti-cancer Drugs) Raw Materials
Table 94. Oncology (Anti-cancer Drugs) Raw Materials Suppliers in Global Market
Table 95. Typical Oncology (Anti-cancer Drugs) Downstream
Table 96. Oncology (Anti-cancer Drugs) Downstream Clients in Global Market
Table 97. Oncology (Anti-cancer Drugs) Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Oncology (Anti-cancer Drugs) Segment by Type in 2022
Figure 2. Oncology (Anti-cancer Drugs) Segment by Application in 2022
Figure 3. Global Oncology (Anti-cancer Drugs) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Oncology (Anti-cancer Drugs) Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Oncology (Anti-cancer Drugs) Revenue, 2018-2029 (US$, Mn)
Figure 7. Oncology (Anti-cancer Drugs) Sales in Global Market: 2018-2029 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Oncology (Anti-cancer Drugs) Revenue in 2022
Figure 9. By Type - Global Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Oncology (Anti-cancer Drugs) Revenue Market Share, 2018-2029
Figure 11. By Type - Global Oncology (Anti-cancer Drugs) Sales Market Share, 2018-2029
Figure 12. By Type - Global Oncology (Anti-cancer Drugs) Price (USD/MT), 2018-2029
Figure 13. By Application - Global Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Oncology (Anti-cancer Drugs) Revenue Market Share, 2018-2029
Figure 15. By Application - Global Oncology (Anti-cancer Drugs) Sales Market Share, 2018-2029
Figure 16. By Application - Global Oncology (Anti-cancer Drugs) Price (USD/MT), 2018-2029
Figure 17. By Region - Global Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Oncology (Anti-cancer Drugs) Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Oncology (Anti-cancer Drugs) Revenue Market Share, 2018-2029
Figure 20. By Region - Global Oncology (Anti-cancer Drugs) Sales Market Share, 2018-2029
Figure 21. By Country - North America Oncology (Anti-cancer Drugs) Revenue Market Share, 2018-2029
Figure 22. By Country - North America Oncology (Anti-cancer Drugs) Sales Market Share, 2018-2029
Figure 23. US Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Oncology (Anti-cancer Drugs) Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Oncology (Anti-cancer Drugs) Sales Market Share, 2018-2029
Figure 28. Germany Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2029
Figure 29. France Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Oncology (Anti-cancer Drugs) Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Oncology (Anti-cancer Drugs) Sales Market Share, 2018-2029
Figure 37. China Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2029
Figure 41. India Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Oncology (Anti-cancer Drugs) Revenue Market Share, 2018-2029
Figure 43. By Country - South America Oncology (Anti-cancer Drugs) Sales Market Share, 2018-2029
Figure 44. Brazil Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Oncology (Anti-cancer Drugs) Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Oncology (Anti-cancer Drugs) Sales Market Share, 2018-2029
Figure 48. Turkey Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2018-2029
Figure 52. Global Oncology (Anti-cancer Drugs) Production Capacity (K MT), 2018-2029
Figure 53. The Percentage of Production Oncology (Anti-cancer Drugs) by Region, 2022 VS 2029
Figure 54. Oncology (Anti-cancer Drugs) Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 腫瘍学（抗がん剤）の世界市場見通し2023年-2029年(Oncology (Anti-cancer Drugs) Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 非ステロイド性抗炎症薬（NSAID）の世界市場見通し2023年-2029年
  • 世界の腫瘍/がん治療薬市場2023-2027
  • 抗てんかん薬の世界市場見通し2023年-2029年
  • 抗老化薬の世界市場見通し2023年-2029年
  • 抗統合失調症薬の世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆